Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type

This study has been terminated.
(The study was discontinued prematurely on 25 February 2008 due to slow enrollment)
Sponsor:
Information provided by (Responsible Party):
Solvay Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00160147
First received: September 8, 2005
Last updated: January 29, 2015
Last verified: June 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2008
  Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: January 29, 2015